JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
REGN - Regeneron Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary REGN Stock
Financials
Financials REGN Stock
Loading...
Loading...
Income Statement
Income Statement REGN Stock
Balance Sheet
Balance Sheet REGN Stock
Cash Flow Statement
Cash Flow Statement REGN Stock
Loading...
Loading...
REGN Financials - Regeneron Pharmaceuticals Income & Cash Flow | Ledgeburg
Home
Stocks
Regeneron Pharmaceuticals, Inc. (REGN)
Financials
Financials of REGN
Loading...
Loading...
Loading...
Loading...
Revenue
$14.3429B
Operating Income
$3.5779B
Net Income
$4.5049B
Share Count (Basic)
104.6M
Operating Cash Flow
$4.9789B
Free Cash Flow
$4.0805B
Cash And Short-Term Equivalents
$8.6052B
Total Debt
$1.9859B
Annual
Quarterly
Revenue $USD
0
5B
10B
15B
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
1B
2B
3B
4B
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
0
2B
4B
6B
8B
Annual
Quarterly
Margins
Gross
Operating
Net
0%
20%
40%
60%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
500M
1B
1.5B
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
10%
20%
30%
40%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26